Combined delivery of BCNU and VEGF siRNA using amphiphilic peptides for glioblastoma

Journal of Drug Targeting

Volumn 22, Issue 2, 2014, Pages 156-164

  Yi, Na ^a   Oh, Binna ^a   Kim, Hyun Ah ^a   Lee, Minhyung ^a  

^a Hanyang University   (South Korea)

Author keywords

Combined delivery; Glioblastoma; Peptide micelles; VEGF siRNA

Indexed keywords

CARMUSTINE; CARRIER PROTEIN; LIPOFECTAMINE; SMALL INTERFERING RNA; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; GENETIC TRANSFECTION; GLIOBLASTOMA; HYDROPHOBICITY; IN VITRO STUDY; MICELLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; ARGININE; CARMUSTINE; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; GENETIC THERAPY; GLIOBLASTOMA; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICELLES; PEPTIDES; RATS; RNA, SMALL INTERFERING; SURFACE-ACTIVE AGENTS; TRANSFECTION; VALINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84891799565     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2013.850502     Document Type: Article

References (16)

1. Mrugala MM, Chamberlain MC. Mechanisms of disease: temozolomide and glioblastoma-look to the future. Nat Clin Pract Oncol 2008;5:476-86.
2. Van Meir EG, Hadjipanayis CG, Norden AD, et al. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 2010;60:166-93.
3. Chamberlain MC, Kormanik PA. Practical guidelines for the treatment of malignant gliomas. West J Med 1998;168: 114-20.
4. Liu S, Guo Y, Huang R, et al. Gene and doxorubicin co-delivery system for targeting therapy of glioma. Biomaterials 2012;33: 4907-16.
5. Meister G, Tuschl T. Mechanisms of gene silencing by doublestranded RNA. Nature 2004;431:343-9.
6. Oh YK, Park TG. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev 2009;61:850-62.
7. Roskoski Jr R. Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 2007;62: 179-213.
8. Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192-8.
9. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
10. Pralhad T, Madhusudan S, Rajendrakumar K. Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases. J Pharm Pharmacol 2003;55:1045-53.
11. Westphal M, Hilt DC, Bortey E, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 2003;5:79-88.
12. Drablos F, Feyzi E, Aas PA, et al. Alkylation damage in DNA and RNA-repair mechanisms and medical significance. DNA Repair (Amst) 2004;3:1389-407.
13. Ryu DW, Kim HA, Song H, et al. Amphiphilic peptides with arginines and valines for the delivery of plasmid DNA. J Cell Biochem 2011;112:1458-66.
14. Lee J, Hyun H, Kim J, et al. Dexamethasone-loaded peptide micelles for delivery of the heme oxygenase-1 gene to ischemic brain. J Control Rel 2012;158:131-8.
15. Park JH, Kim HA, Cho SH, Lee M. Characterization of hydrophobic anti-cancer drug-loaded amphiphilic peptides as a gene carrier. J Cell Biochem 2012;113:1645-53.
16. Park JH, Kim HA, Park JH, Lee M. Amphiphilic peptide carrier for the combined delivery of curcumin and plasmid DNA into the lungs. Biomaterials 2012;33:6542-50.